| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -4.3e-05 | 1 |